funding history / development milestones

A++轮,融资金额未公开

2025.12.16, 光谷科创投

B轮,1740万美元

股权融资,1740万美元

A+轮,逾1.9亿美元

A轮,1.25亿美元

2020.01.01

天使轮,融资金额未公开

Note: collected from public online reports, for reference only.

People who follow this company also follow

Competitors (Similar Companies)

“Leading enterprise in Hubei pharmaceutical industry, one of China's to”
“A large Taiwan-invested enterprise mainly producing touch control prod”
“Main business: design, manufacture, and sales of printed circuit board”
“Committed to providing green, safe, affordable and abundant biopharmac”
“Trustworthy biological experiment service provider”
“成为中国医药研发CRO旗舰企业”
“Mainly engaged in the research, development and production of active p”
“A technology-driven international pharmaceutical enterprise”
“Dedicated to animal health technology to enhance life quality”
医药 生物医药 医药科技 医疗科技
“A high-tech enterprise integrating pharmaceutical production, R&D, and”
“It is a large high-tech enterprise integrating production, education, ”
“Major sheet metal parts supplier for large well-known enterprises”
工厂 医药CDMO 生物创新 生长激素
“Plant genetic engineering service provider”